"My mission is to further our knowledge of disease-related cellular signaling and to develop novel, high-impact therapeutics."

Vishva Mitra Dixit (born c. 1956) is a Kenyan-American physician who is currently Vice President and Senior Fellow of Physiological Chemistry and Research Biology at Genentech. [1]

Dec 12, 2022 · Dixit, Senior Fellow and Vice President of Early Discovery Research, Physiological Chemistry at Genentech, was elected to the National Academy of Sciences (NAS) in 2013 and …

Vishva M. Dixit is presently Vice President of Early Discovery Research at Genentech Inc. He has made many contributions to biomedicine and his early work on cell death and...

Feb 8, 2019 · Vishva M. Dixit, M.D., Vice President of Physiological Chemistry at Genentech, Inc. has made many contributions to biomedicine, and his early work on apoptosis is prominent in...

G Pan, J Ni, YF Wei, G Yu, R Gentz, VM Dixit. Science 277 (5327), 815-818, 1997. 2124: 1997: Signaling in innate immunity and inflammation. K Newton, VM Dixit. Cold Spring Harbor …

Interested in cell death, inflammation and ubiquitin modification. Foreign Member, European Molecular Biology Organization, a member of the Institute of Medicine, the American Academy...

Vishva M. Dixit is Vice President of Discovery Research at Genentech. A pathologist by training, he has studied molecular mechanisms that underlie cell death and inflammatory signaling.

Sep 9, 2022 · The question of how we live while our cells are continuously dying has captivated Dr. Vishva Dixit. After a long career in academia, Dixit ( Figure 1 ) rose through the ranks at …